Navigation Links
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
Date:1/7/2008

Breakthrough, Potential Blockbuster Product for High Risk Cardiovascular

Patients

CAMBRIDGE, Mass. and CARLSBAD, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that they have entered a major strategic alliance in which Genzyme will develop and commercialize mipomersen, Isis' lipid-lowering treatment for high risk cardiovascular patients that utilizes novel antisense technology. As part of the strategic relationship, Genzyme will also have preferred access to future Isis drugs for CNS and certain rare diseases. The companies will host a webcast conference call today at 5:15 pm EST (2:15 pm PST) to discuss the transaction.

Genzyme will pay Isis $150 million to purchase five million shares of Isis common stock for $30 per share upon Hart-Scott-Rodino clearance. Upon completion of final contracts, Genzyme will pay Isis a $175 million up-front mipomersen license fee. In addition to this initial $325 million, Isis has the potential to receive significant milestone payments for mipomersen, which is currently in phase 3 trials. Once the product is launched, the two companies will share profits.

"This alliance is an excellent strategic fit for Genzyme's business model and culture," said Henri A. Termeer, Genzyme's chairman and chief executive officer. "Mipomersen is an innovative approach to addressing a real unmet medical need, and we believe it could prove to be the most effective lipid-
'/>"/>

SOURCE Genzyme Corp.; Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
2. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
3. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
4. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
5. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
6. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
7. Genzyme Launches Cholestagel(R) in Europe
8. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
9. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
10. Genzyme Recognized by Scientists as a Top Employer
11. Genzyme Receives Approval to Market Elaprase(R) in Japan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The FBI recently approved th...tories participating in or generating DNA records ... Madison, WI USA (PRWEB) -- The FBI rec...ystem for use by laboratories participating in, o...ex System (NDIS). NDIS currently contains more tha...
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswir...yCalottoCapitalInc.,aleadingproviderofadvancedlase...tilityclinicmarkets,todayreportedoperationalandfin...09. , ,Q32009Highlights,-Revenuewas$1.46millionc...was66.3percentcomparedwith66.1percentinQ3,2008,-Ne...
(Date:11/24/2009)..., SANDIEGO,Nov.24,2009/PRNewswire-FirstCall/--Ar...odaythatthecompanyisscheduledtopresentatthePiperJa...9at11:30a.m.EasternTime(8:30a.m.PacificTime)attheN...esident andChiefExecutiveOfficer,isscheduledtoprov...lopmentanddiscoveryprograms. ,, Aliveaudiowebca...
(Date:11/24/2009)..., BOZEN,Italy,November24/PRNewswire/--HealthRobo...tventurewithagroupofselected,investors.Thisrecentl...eHealthRoboticsCanada,Inc.andwillmarket,install,an...,whichincludesthe,revolutionaryproductofferingsi.v...csCanadaInc.willalsoprovideassistanceonan"asneeded...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...s Inc. (BCI), a,biopharmaceutical company utilizin...compounds that promote the growth of new neurons f...iseases, announced today that it raised an,additio...nancing, bringing,the total to $50 million. New in... current investors and Alexandria Real Estate Equi...
...s Inc. (BCI), a,biopharmaceutical company utilizin...compounds that promote the growth of new neurons f...iseases, announced today that it raised an,additio...nancing, bringing,the total to $50 million. New in... current investors and Alexandria Real Estate Equi...
...nthera Pharmaceuticals,Inc., a privately held biop... drugs, announced today that Anthera scientists an...ladib (A-002) clinical and,pre-clinical programs a...iology (ATVB) Annual Conference in Atlanta, Georgi... Phase II trials in Varespladib for the,treatment ...
Other Biology Technology:REVISED: BrainCells Inc. Expands Series B Financing to $50 Million 2BrainCells Inc. Expands Series B Financing to $50 Million 2Anthera Presents Data on Varespladib at ATVB Meeting 2
(Date:11/24/2009)...(November 24, 2009) New research on bacterial com...ems reveals predictable temporal patterns, suggest... markers for monitoring climate change in the pola...Proceedings of the National Academy of Sciences E...the six rivers shifted synchronously over time, co...
(Date:11/23/2009)...esearch presents strong evidence that the "synergi...r traffic-related pollution and indoor endotoxin c...e other exposure alone. , Environmental health...ollege of Medicine have shown that children expose... and indoor endotoxin during early life are six ti...
(Date:11/23/2009)...Mass. November 23, 2009 Applied mathematicians d...ta lancifolia ), a characteristic long leaf with a...ples along the edges. The simple cause of the lily... bending during differential growthwas revealed by...m ribbons. , Haiyi Liang, a postdoctoral student...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2WAVE 26apos 3Bs Revolutionary Whole Body Advanced Vibration Exercise Is Now Available in South America 61038 1WAVE 26apos 3Bs Revolutionary Whole Body Advanced Vibration Exercise Is Now Available in South America 61038 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 1Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 3Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 4Thoratec Presentation at Canaccord Adams Conference to be Webcast 6116 1
...(BRONX, NY) Scientists at Albert Einstein College...heir revolutionary new drug-delivery system with a... deadly drug-resistant staph infections in mice. T...sion of the Journal of Investigative Dermatology ...jority of superficial and invasive skin infections...
...ussell A. Mittermeier, the president of Conservati...ty conservation, has received the Roger Tory Peter...ry. , Mittermeier is a renowned field biologist a...an 500 scientific and popular articles, along with...ecies new to science, had seven others named after...
... Calif.) Scientists at UC Santa Barbara have made...human embryonic stem cells function. , They expla... will renew, or will transform to become part of a...y. The study is reported in the May 1 issue of the... bodes well for cancer research, since tumor stem ...
Other Biology News:New technology shows promise against resistant staph infections 2New technology shows promise against resistant staph infections 3Scientists shed light on inner workings of human embryonic stem cells 2Scientists shed light on inner workings of human embryonic stem cells 3
Rabbit Anti-GLYCINE Polyclonal Antibody, Unconjugated from AbD Serotec
beta-Secretase Fluorometric (EDANS / DABCYL) Assay Kit from R&D Systems
...The Light Diagnostics Cytomegalovirus (CMV) pp65 A...ded for the qualitative identification of lower ma...ood leukocytes. Kit Components: Erythrocyte L...ning 220 mL of buffered ammonium chloride. (NH4CL)...
Human Anti-NP Chimaeric IgA2 Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: